Decrease in the AgNOR number in Dunning R3327 prostate cancers after treatment with an agonist and antagonist of luteinizing hormone-releasing hormone.

Por Szepeshazi, K., Korkut, E., Schally, A. V.
Publicado em 1991

Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers

Por Bajo, A M, Schally, A V, Groot, K, Szepeshazi, K
Publicado em 2004

Inhibition of growth of OV-1063 human epithelial ovarian cancers and c- jun and c- fos oncogene expression by bombesin antagonists

Por Chatzistamou, I, Schally, A V, Sun, B, Armatis, P, Szepeshazi, K
Publicado em 2000

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

Por Yano, T, Pinski, J, Halmos, G, Szepeshazi, K, Groot, K, Schally, A V
Publicado em 1994

Targeted cytotoxic analogue of bombesin/ gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice

Por Kiaris, H, Schally, A V, Nagy, A, Sun, B, Armatis, P, Szepeshazi, K
Publicado em 1999

Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.

Por Pinski, J., Schally, A. V., Halmos, G., Szepeshazi, K., Groot, K., O'Byrne, K., Cai, R. Z.
Publicado em 1994

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215

Por Szereday, Z, Schally, A V, Nagy, A, Plonowski, A, Bajo, A M, Halmos, G, Szepeshazi, K, Groot, K
Publicado em 2002

Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

Por Szepeshazi, K, Schally, A V, Groot, K, Armatis, P, Halmos, G, Hebert, F, Szende, B, Varga, J L, Zarandi, M
Publicado em 2000

Localization of receptors for luteinizing hormone-releasing hormone in pancreatic and mammary cancer cells.

Por Szende, B, Srkalovic, G, Timar, J, Mulchahey, J J, Neill, J D, Lapis, K, Csikos, A, Szepeshazi, K, Schally, A V
Publicado em 1991

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent.

Por Nagy, A, Schally, A V, Armatis, P, Szepeshazi, K, Halmos, G, Kovacs, M, Zarandi, M, Groot, K, Miyazaki, M, Jungwirth, A, Horvath, J
Publicado em 1996